Highbridge Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1277 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1218 |
|
|
2017
Q2 | – | Sell |
-33,510
| Closed | -$887K | – | 1303 |
|
|
2017
Q1 | $887K | Buy |
33,510
+15,418
| +85% | +$408K | 0.01% | 551 |
|
|
2016
Q4 | $462K | Buy |
+18,092
| New | +$462K | 0.01% | 668 |
|
|
2016
Q2 | – | Sell |
-20,978
| Closed | -$553K | – | 1389 |
|
|
2016
Q1 | $553K | Buy |
+20,978
| New | +$553K | 0.01% | 525 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1153 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 1099 |
|
|
2014
Q4 | – | Sell |
-7,286
| Closed | -$220K | – | 1090 |
|
|
2014
Q3 | $220K | Sell |
7,286
-6,516
| -47% | -$197K | ﹤0.01% | 775 |
|
|
2014
Q2 | $469K | Buy |
+13,802
| New | +$469K | 0.01% | 528 |
|